Legal Opinion
Chapman v. AstraZeneca Pharmaceuticals LP
Superior Court of Delaware
Decided October 3, 2022No. N17C-04-320 PPIPublished
1Opinion of the Court
IN THE SUPERIOR COURT OF THE STATE OF DELAWARE DEBORAH CHAPMAN, ) ) Plaintiff, ) ) C.A. No. N17C-04-320 PPI v. ) ) ASTRAZENECA ) PHARMACEUTICALS LP; and ) ASTRAZENACE LP, ) ) Defendants. Submitted: July 7, 20221 Decided: October 3, 2022 Upon Defendants’ Motion to Exclude Opinion Testimony from Dr. Gaurav Jain under Delaware Rule of Evidence 702 GRANTED Upon Defendants’ Motion for Summary Judgment GRANTED Upon Defendants’ Motion to Exclude Opinion Testimony from Dr. Robert Weiss under Delaware Rule of Evidence 702 MOOT I. INTRODUCTION This is a personal injury action involving product…
2Cases cited8 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Getz v. StateSupreme Court of Delaware · 1988
- Bowen v. EI DuPont De Nemours & Co., Inc.Supreme Court of Delaware · 2006
- Sheehan v. Oblates of St. Francis de SalesSupreme Court of Delaware · 2011
- Riegel v. Aastad Ex Rel. AastadSupreme Court of Delaware · 1970
3 more not listed; retrieve them via the Exa API.